Kitti K. Chan
Singapore, 169857, Singapore
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
In Vitro and In Vivo Stability of P884T, a Mutation that Relocalizes Dengue Virus 2 Non-structural Protein 5.
Journal: ACS infectious diseases
Published: November 04, 2021
Non-nucleoside Inhibitors of Zika Virus RNA-Dependent RNA Polymerase.
Journal: Journal of virology
Published: April 27, 2020
Subgenomic RNA from Dengue Virus Type 2 Suppresses Replication of Dengue Virus Genomes and Interacts with Virus-Encoded NS3 and NS5 Proteins.
Journal: ACS infectious diseases
Published: January 11, 2020
A Non-structural 1 Protein G53D Substitution Attenuates a Clinically Tested Live Dengue Vaccine.
Journal: Cell reports
Published: November 17, 2019
A systematic approach to the development of a safe live attenuated Zika vaccine.
Journal: Nature communications
Published: November 29, 2017
NS3 helicase from dengue virus specifically recognizes viral RNA sequence to ensure optimal replication.
Journal: Nucleic acids research
Published: August 24, 2017
The C-terminal 18 Amino Acid Region of Dengue Virus NS5 Regulates its Subcellular Localization and Contains a Conserved Arginine Residue Essential for Infectious Virus Production.
Journal: PLoS pathogens
Published: May 14, 2016
The C-terminal 50 amino acid residues of dengue NS3 protein are important for NS3-NS5 interaction and viral replication.
Journal: The Journal of biological chemistry
Published: December 10, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026